Hepatitis B (HBsAg) Rapid Antigen Test

Viral hepatitis is a systemic disease that primarily targets the liver, causing inflammation and potentially leading to liver damage or failure. The most common causes of acute viral hepatitis are the Hepatitis A, Hepatitis B (HBV), and Hepatitis C viruses. Among these, Hepatitis B is a particularly significant cause of liver disease globally. The virus is known for its complex surface antigen, HBsAg (Hepatitis B surface antigen), which plays a key role in the diagnosis of HBV infections. HBsAg is one of the first serological markers to appear in the blood of infected individuals, often detectable as early as two to three weeks before clinical symptoms of infection manifest. This early detection of HBsAg is crucial for timely diagnosis and management of the infection.

Detection of HBsAg in blood, typically in serum or plasma, is a primary diagnostic tool for identifying both acute and chronic active Hepatitis B infections. The presence of HBsAg indicates that an individual is currently infected with the virus. During the acute phase, the level of HBsAg in the blood tends to rise, particularly as the infection becomes symptomatic, and may decrease as the body begins to clear the virus. Monitoring HBsAg levels can also help healthcare providers distinguish between acute and chronic infections, as persistent high levels of HBsAg may indicate a long-term active infection, which can lead to chronic liver damage if left untreated.

The Hepatitis B (HBsAg) Rapid Antigen Test is a simple and efficient tool for the rapid detection of HBsAg in serum or plasma specimens. This immunochromatographic assay is designed to detect the presence of HBsAg quickly and with high accuracy, providing results in as little as 10-15 minutes. This fast turnaround time is essential for clinicians who need to make prompt decisions regarding treatment and management of Hepatitis B. If the test result is positive, immediate medical intervention can be initiated, which is critical in preventing the progression of liver damage and minimizing the risk of transmission to others.

This rapid antigen test is ideal for use in clinical settings, including hospitals, clinics, and screening programs. Its easy-to-use format and quick results make it an invaluable tool for healthcare professionals in diagnosing Hepatitis B infections and managing patient care efficiently. Early detection using the Hepatitis B (HBsAg) Rapid Antigen Test is key to initiating timely treatment, potentially preventing severe liver damage, and improving overall outcomes for infected individuals. The test also plays an important role in preventing transmission, particularly in high-risk populations or during routine screening efforts.

Sample types: serum or plasma

Sensitivity: 98.5 %

Specificity: 99%

LoD: 1 ng/mL or 2 IU/mL

Q-Check Hepatitis B (HBsAg) Rapid Antigen Test                                                                                                           25T/Box                          QCH-0004-25

                                                           Single Test/Box                QCH-0004-1